Delivery Order SPE2DB24D2205-SPE2DB25FEBHP

Award Date 4/22/25
Potential Completion Date 4/23/25
Potential Value $25K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $9,876.74, is for the delivery of 4,567,957,360 units of the diabetes medication Jardiance 25 mg tablets. The contract has an ultimate completion date of April 18, 2025 and is not set aside for a specific business type. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,494.05 contract is for the supply of 4,567,951,867 units of the diabetes medication Jardiance 25 mg tablets. The award has an ultimate completion date of April 18, 2025 and was made on April 17, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,395.70, is for the supply of 4,568,142,300 units of the diabetes medication Jardiance 25 mg tablets. The contract has a performance period through May 6, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,567,919,224 units of the diabetes medication Jardiance 25 mg tablets. The total ceiling value of the contract is $4,627.60, with a period of performance through April 16, 2025. This contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,011,590 units of the diabetes medication Jardiance 25 mg tablets. The contract has a ceiling value of $3,758.40 and a period of performance ending on April 24, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,568,175,223 units of the diabetes medication Jardiance 25 mg tablets. The contract has a ceiling value of $13,819.22 and a completion date of May 8, 2025. It is a firm fixed-price contract, and there is no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,870,676 units of Jardiance 10 mg tablets, a diabetes medication, with a ceiling value of $6,268.75. The contract has an ultimate completion date of April 11, 2025 and was awarded on April 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $31,906.81, is for the delivery of 4,567,957,203 units of the diabetes medication Jardiance 25 mg tablet with a completion date of April 18, 2025. This contract is not designated as a set-aside and is considered an open competition. AmerisourceBergen Drug Corp holds a significant...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is valued at $38,548.22 and has an ultimate completion date of April 30, 2025. It is for the provision of 4,568,076,618 units of the diabetes medication Jardiance 25 mg tablet in 90-count packages. The contract is not set-aside and represents an open competition award. AmerisourceBergen Drug...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $34,145.46 firm-fixed-price contract is for the delivery of 4,568,175,187 units of the diabetes medication Jardiance 25 mg tablets. The contract has a period of performance through May 8, 2025 and is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEBHP
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,996,072 units of the diabetes medication Jardiance 25 mg tablets. The contract has a ceiling value of $25,342.73 and a period of performance through April 23, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. The contract is not set aside and represents open competition. AmerisourceBergen is positioned as a critical vendor supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/22/25, 10:08 AM